Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes H A M Kaanders

Showing results (1-10 of 196) with videos related to

Pageof 20
Sort By:
Lancet (London, England)|June 6, 2022
Head and neck cancer: high-end technology is no guarantee of high-quality careJohannes H A M Kaanders
European Journal of Cancer (Oxford, England : 1990)|June 9, 2005
Biological surrogate end-points in cancer trials: potential uses, benefits and pitfallsRachel Cooper, Johannes H A M Kaanders
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 27, 2002
Carcinoma of the larynx: the Dutch national guideline for diagnostics, treatment, supportive care and rehabilitationJohannes H A M Kaanders, Gerrit Jan Hordijk,
International Journal of Radiation Oncology, Biology, Physics|December 14, 2025
Elective Neck Irradiation: "Thou Shalt Not Harm!"Sven van den Bosch, Johannes H A M Kaanders
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2016
Engineered microparticles delivering oxygen to enhance radiotherapy efficacyPaul N Span, Johan Bussink, Johannes H A M Kaanders
Radiation Oncology (London, England)|March 19, 2013
Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescriptionAswin L Hoffmann, Henk Huizenga, Johannes H A M Kaanders
Lancet (London, England)|January 16, 2004
Erythropoietin to treat anaemia in patients with head and neck cancerJohannes H A M Kaanders, Albert J van der Kogel
JAMA Otolaryngology-- Head & Neck Surgery|May 19, 2022
Comparison of Patients With Head and Neck Cancer in Randomized Clinical Trials and Clinical Practice: A Systematic ReviewJohannes H A M Kaanders, Sven van den Bosch, Jos Kleijnen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2025
Reply to: Caution Needed Before Adopting Reduced-Dose Elective Neck Irradiation in Head and Neck Cancer: A Response to UPGRADE-RTSven van den Bosch, Gerjon Hannink, Johannes H A M Kaanders
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 22, 2003
Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markersJohan Bussink, Johannes H A M Kaanders, Albert J van der Kogel
Pageof 20

Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
Lancet (London, England)|June 6, 2022
Head and neck cancer: high-end technology is no guarantee of high-quality careJohannes H A M Kaanders
European Journal of Cancer (Oxford, England : 1990)|June 9, 2005
Biological surrogate end-points in cancer trials: potential uses, benefits and pitfallsRachel Cooper, Johannes H A M Kaanders
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 27, 2002
Carcinoma of the larynx: the Dutch national guideline for diagnostics, treatment, supportive care and rehabilitationJohannes H A M Kaanders, Gerrit Jan Hordijk,
International Journal of Radiation Oncology, Biology, Physics|December 14, 2025
Elective Neck Irradiation: "Thou Shalt Not Harm!"Sven van den Bosch, Johannes H A M Kaanders
Proceedings of the National Academy of Sciences of the United States of America|December 9, 2016
Engineered microparticles delivering oxygen to enhance radiotherapy efficacyPaul N Span, Johan Bussink, Johannes H A M Kaanders
Radiation Oncology (London, England)|March 19, 2013
Employing the therapeutic operating characteristic (TOC) graph for individualised dose prescriptionAswin L Hoffmann, Henk Huizenga, Johannes H A M Kaanders
Lancet (London, England)|January 16, 2004
Erythropoietin to treat anaemia in patients with head and neck cancerJohannes H A M Kaanders, Albert J van der Kogel
JAMA Otolaryngology-- Head & Neck Surgery|May 19, 2022
Comparison of Patients With Head and Neck Cancer in Randomized Clinical Trials and Clinical Practice: A Systematic ReviewJohannes H A M Kaanders, Sven van den Bosch, Jos Kleijnen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2025
Reply to: Caution Needed Before Adopting Reduced-Dose Elective Neck Irradiation in Head and Neck Cancer: A Response to UPGRADE-RTSven van den Bosch, Gerjon Hannink, Johannes H A M Kaanders
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 22, 2003
Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markersJohan Bussink, Johannes H A M Kaanders, Albert J van der Kogel
Pageof 20